Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,649,749
-
Share change
-
+6,292,962
-
Total reported value
-
$101,955,635
-
Price per share
-
$8.06
-
Number of holders
-
48
-
Value change
-
+$50,345,978
-
Number of buys
-
35
-
Number of sells
-
11
Institutional Holders of RECRO PHARMA INC - COM (SCTL) as of Q4 2016
As of 31 Dec 2016,
RECRO PHARMA INC - COM (SCTL) was held by
48 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,649,749 shares.
The largest 10 holders included
Broadfin Capital, LLC, Stonepine Capital Management, LLC, DEERFIELD MANAGEMENT CO, Alyeska Investment Group, L.P., Tourbillon Capital Partners, L.P., Cormorant Asset Management, LLC, VANGUARD GROUP INC, KINGDON CAPITAL MANAGEMENT, L.L.C., ACUTA CAPITAL PARTNERS, LLC, and BlackRock Institutional Trust Company, N.A..
This page lists
48
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.